Company: DVAX
Filing Date: 2025-05-13
Form Type: 8-K
Source: 0001029142-25-000081
Chunk: 1

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-05-13
Form: 8-K
Item: Item 5.02
Chunk 1
---
 form of indemnification agreement with Mr. Metzinger. A form of the indemnification agreement was previously filed by the Company as Exhibit 10.1 to its Quarterly Report on Form 10-Q filed with Securities and Exchange Commission (the “ SEC”) on November 7, 2019. The Company also intends to enter into its standard form of Management Continuity and Severance Agreement (“ MCSA”) with Mr. Metzinger. A form of the MCSA was previously filed by the Company as Exhibit 10.3 to its Quarterly Report on Form 10-Q filed with the SEC on August 3, 2023.

Mr. Metzinger was not appointed as the Company’s Vice President, Chief Accounting Officer and principal accounting officer pursuant to any arrangement or understanding with any other person. Mr. Metzinger does not have any family relationships with any executive officer or director of the Company and he is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                                        Dynavax Technologies Corporation  
  Date:      May 13, 2025      By:      /s/ Kelly MacDonald               
                                        Kelly MacDonald